Power

Renewable Energy

Aviation

Healthcare

Corporate

Capital

Corporate items and eliminations

Commercial Engines & Services

Defense & Propulsion Technologies

Corporate & Other

Consolidated revenues

Revenue segments as reported by the company.

Sales of equipment

Sales of services

Insurance revenues

Sales of goods and services

GE Capital revenues from services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research & development

Interest and other financial charges

Insurance liabilities and annuity benefits

Goodwill impairments

Non-operating benefit costs

Other costs and expenses

Other Income

Debt extinguishment costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

General Electric

Baker Hughes is an international industrial service company and one of the world's largest oil field services companies. As of July 2017 Baker Hughes is 62.5% owned by General Electric Company and 37.5% publicly traded. It operates in more than 120 countries, providing the oil and gas industry with products and services for oil drilling, formation evaluation, completion, production and reservoir consulting.

Baker Hughes

GE Capital is the financial services unit of the American multinational conglomerate General Electric. It provides commercial lending and leasing, as well as a range of financial services for commercial aviation, energy, and support for GE's industrial business units. In 2015, GE announced its plan to create a simpler, more valuable company by reducing the size of its financial businesses through the sale of most GE Capital assets.

GE Capital

GE Aerospace is an American aircraft company, which provides jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. Its portfolio of brands includes Avio Aero, Unison, GE Additive and Dowty Propellers. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Cincinnati, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

General Electric (GE) posts robust Q4 earnings, eyes profit growth

General Electric (GE) delivered a strong performance in Q4 2022 with revenue growth, margin expansion, and significant EPS growth. While facing challenges in renewables and margin pressure in Aerospace, GE is focused on capital allocation, cash flow conversion, and profit growth opportunities.

General Electric (GE) reports robust Q1 results and advances business separations

General Electric (GE) delivered strong Q1 results with revenue growth, margin expansion, and positive cash flow across segments.
The company is optimistic about future performance, focusing on profitability and growth while advancing plans to launch GE Aerospace and GE Vernova as independent companies.
Challenges include evolving pricing dynamics, Defense growth hurdles, and Offshore Wind order expectations, but opportunities lie in market shifts and selective pursuits for fair compensation.

General Electric surpasses expectations in Q2, raises full-year guidance

General Electric's Q2 2023 earnings call highlighted strong financial performance, particularly in Aerospace and Vernova segments. Despite challenges in Renewables and Power, GE is optimistic about future growth opportunities and remains focused on profitability and cash flow improvements. The company's strategic focus on key segments and product development bodes well for its long-term success.

GE Aerospace shines in Q3, plans spin-offs for growth

General Electric (GE) had a strong quarter, with Aerospace leading the way in revenue growth and margin expansion. Despite challenges in Offshore Wind and Defense supply chains, the company remains optimistic about future prospects. GE's focus on innovation and operational improvements positions it well for continued success.

General Electric triples earnings in 2023, eyes strong 2024 growth

GE's strong performance in 2023 sets the stage for continued growth in 2024, with both GE Aerospace and Vernova expected to drive revenue, profit, and cash growth. Despite challenges from engine production and renewables, GE is well-positioned to capitalize on opportunities for expansion and value creation.

GE Aerospace excels in Q1, eyes $10B profit target by 2028

GE Aerospace's Q1 performance was robust, with significant profit and revenue growth. While facing challenges like lower LEAP production, the company is leveraging its strengths in propulsion and services. Opportunities lie in R&D investments, new contracts, and efficiency improvements through technology advancements.

General Electric reports robust Q2 earnings, eyes growth amid challenges

General Electric's Q2 performance reflects strong growth in key segments, underpinned by strategic investments and operational improvements.
While facing supply chain challenges, GE's focus on innovation, sustainability, and customer service presents opportunities for future growth and market leadership.
By addressing operational hurdles and leveraging its strengths, GE is poised to capitalize on market opportunities and deliver sustained profitability.

General Electric's Aerospace shines in Q3, eyes growth opportunities

General Electric's Q3 2024 earnings call showcased strong performance in the Aerospace segment, with positive outlooks for growth and profitability. The company's focus on operational improvements, strategic planning, and collaboration with key partners positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

General Electric Co. set the terms for the spinoff of its healthcare division, putting an initial value of roughly $31 billion on the soon-to-be-public company.

GE Puts $31 Billion Value on Healthcare Spinoff

General Electric Co. GE, +0.36% said Wednesday that its board of directors has approved the previously announced spin-off of GE HealthCare, its health care business. GE HealthCare will become a corporation and be renamed GE HealthCare Technologies Inc. The company is expected to begin trading on the Nasdaq on Jan. 4, GE said.

GE board OKs awaited GE HealthCare spin-off

BOSTON--( BUSINESS WIRE )--GE (NYSE:GE) announces its acceptance of approximately $7.0 billion in aggregate purchase price (excluding the accrued and unpaid interest on such Securities) (the “Total Maximum Amount”) of the securities listed in the table below (such securities, the “Securities” and, such offer to purchase, the “Tender Offer”). GE is accepting for purchase the aggregate purchase price of all Securities with acceptance priority levels set forth in the table below (the “Acceptance Priority Levels”) 1 and 2, and the Securities with Acceptance Priority Level 3 on a pro rata basis up to the Total Maximum Amount, using a proration factor of approximately 46.42%, that were validly tendered and not validly withdrawn at or prior to 5:00 p.m., New York City time, on November 22, 2022 (such date and time, the “Early Participation Date”).

GE Announces Total Consideration and Amounts Accepted in its Debt Tender Offer: Expects to Repurchase Approximately $7.2 Billion in Principal Amount on December 2, 2022

BOSTON--( BUSINESS WIRE )--General Electric Company (“GE”) (NYSE: GE) announced today that its Board of Directors has approved the previously announced spin-off of its healthcare business, GE Healthcare Holding LLC (“GE HealthCare”). Prior to such spin-off, GE HealthCare is expected to be converted into a corporation and renamed GE HealthCare Technologies Inc. The company is expected to begin trading on Nasdaq on January 4, 2023, under the ticker “GEHC”.

GE Board of Directors Approves Separation of GE HealthCare

L3Harris

Aerojet Rocketdyne Holdings

Industrial conglomerate General Electric Co and defense contractor L3Harris Technologies Inc are among those competing to acquire rocket maker Aerojet Rocketdyne Holdings Inc , according to people familiar with the matter.

Exclusive: General Electric, L3Harris among suitors vying for Aerojet -sources

CHICAGO--( BUSINESS WIRE )--GE Healthcare announced today that it was recognized in the annual ‘Best of What's New' awards by Popular Science Magazine. The award highlights GE Healthcare's AIR Recon DL technology and the benefits it brings to the healthcare industry.

GE Healthcare's AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What's New' Awards

General Electric's (GE) Healthcare unit collaborates with Ulrich Medical to offer a multi-dose syringeless injector under the brand name CT Motion.

General Electric (GE) to Offer CT Motion Injector in U.S.

CHICAGO--( BUSINESS WIRE )--GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and MediView XR, Inc., a leading clinical augmented reality med-tech company, announced today their collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR™ Interventional Suite System.1 MediView's current technology platform leverages spatial computing and mixed reality, united with medical imaging in combining augmented reality visualization, seamless remote collaboration and evidence-based clinical insights.

MediView and GE Healthcare to Bring Augmented Reality Solutions to Medical Imaging for the Interventional Space

MARLBOROUGH, Mass.--( BUSINESS WIRE )--GE Healthcare has today announced an agreement with ulrich medical for a GE Healthcare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector, which delivers iodinated contrast media for Computed Tomography (CT) imaging procedures, reduces procedure setup time and increases patient throughput by eliminating time consuming preparation steps, while helping to optimize patient dosing and reduce wasted contrast media.

GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

CHICAGO--( BUSINESS WIRE )--GE Healthcare today announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey. This integrated collection works together to ensure the smoothest magnetic resonance imaging (MRI) scanning experience possible for the physician, technologists of all skill levels, and the patient.

GE Healthcare Introduces SIGNA Experience: A New Platform of Transformative Technologies that Leverage the Power of AI and Deep-Learning in MRI Scanning

CHICAGO--( BUSINESS WIRE )--Ahead of its planned spinoff from GE the first week of January 2023, GE Healthcare reveals over 40 solutions that aim to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North America's (RSNA) 2022 Annual Meeting.

GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

GE (GE) reported earnings 30 days ago. What's next for the stock?

GE (GE) Up 16.5% Since Last Earnings Report: Can It Continue?

BOSTON--( BUSINESS WIRE )--GE (NYSE:GE) today announced the applicable “Reference Yield” for each series of Securities (as defined below) for its previously announced offer to purchase for cash, for its own account and on behalf of the Subsidiary Issuers (as defined below), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated November 8, 2022 (as amended or supplemented from time to time, the “Offer to Purchase”) for cash up to $7,000,000,000 (as converted on the basis set forth herein) (excluding the accrued and unpaid interest on such Securities) aggregate purchase price (the “Total Maximum Amount”) of the securities listed in the table below (such securities, the “Securities” and, such offer to purchase, the “Tender Offer”), issued by GE or an affiliate (and assumed or guaranteed by GE). Given the aggregate principal amount of the Securities validly tendered in the Tender Offer prior to the Early Participation Date, GE expects the aggregate purchase price of such Securities to exceed the Total Maximum Amount.

GE Announces the Applicable Reference Yield for its Debt Tender Offer

BOSTON--( BUSINESS WIRE )--GE (NYSE:GE) announces the results as of 5:00 p.m., New York City time, on November 22, 2022 (the “Early Participation Date”), for its previously announced offer to purchase for cash, for its own account and on behalf of the Subsidiary Issuers (as defined below), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated November 8, 2022 (as amended or supplemented from time to time, the “Offer to Purchase”) for cash up to $7,000,000,000 (as converted on the basis set forth herein) (excluding the accrued and unpaid interest on such Securities) aggregate purchase price (the “Total Maximum Amount”) of the securities listed in the table below (such securities, the “Securities” and, such offer to purchase, the “Tender Offer”), issued, assumed or guaranteed by GE. Given the aggregate principal amount of the Securities validly tendered in the Tender Offer prior to the Early Participation Date, GE expects the aggregate purchase price of such Securities to exceed the Total Maximum Amount.

GE Announces Early Participation Results in Its Debt Tender Offer

BOSTON--( BUSINESS WIRE )--General Electric Company (“GE”) (NYSE: GE) announced today that GE Healthcare Holding LLC (“GE HealthCare”), a direct, wholly-owned subsidiary of GE, has closed its previously announced offering of $1,000,000,000 aggregate principal amount of 5.550% senior notes due 2024 (the “2024 notes”), $1,500,000,000 aggregate principal amount of 5.600% senior notes due 2025 (the “2025 notes”) and $1,750,000,000 aggregate principal amount of 5.650% senior notes due 2027 (the “2027 notes” and, together with the 2024 notes and the 2025 notes, the “New Money Notes”), $1,250,000,000 aggregate principal amount of 5.857% senior notes due 2030 (the “2030 notes”), $1,750,000,000 aggregate principal amount of 5.905% senior notes due 2032 (the “2032 notes”), and $1,000,000,000 aggregate principal amount of 6.377% senior notes due 2052 (the “2052 notes” and, together with the 2030 notes and the 2032 notes, the “SpinCo Debt Securities” and, together with the New Money Notes, the “Notes”).

GE Announces Closing of Offering of $8.25 Billion Senior Notes issued by GE HealthCare

CHICAGO--( BUSINESS WIRE )--Today, as radiology departments face challenges in a new era of healthcare, GE Healthcare imaging solutions are designed to support clinicians in meeting competing demands for their time and enable greater focus on patient care. Imaging experts are in short supply and high demand while, at the same time, imaging is moving beyond hospital campuses. By 2033, the U.S. alone could fall short by almost 42,000 of the needed radiologists and other specialist physicians 3 and burnout amongst healthcare professionals is a growing issue. Nearly two-thirds (61%) of radiologists suffer from burnout, up from 36% in 2013 to 49% in 2017. 4

GE Healthcare Imaging Solutions Increase Workflow Efficiency and Optimize Radiologists' Time to Help Reduce Burnout

WAUKESHA, Wis.--( BUSINESS WIRE )--Researchers at the University of Wisconsin–Madison, the first U.S. clinical evaluation site for GE Healthcare's industry-first silicon-based photon counting CTi, will begin human scanning using the device, which is engineered with Deep Silicon detectors with the goal of greatly enhancing imaging capabilities to help clinicians improve patient outcomes across oncology, cardiology, neurology, and other clinical CT applications.

UW–Madison To Perform the First U.S. Evaluation of GE Healthcare's Photon Counting CT Technology with Deep Silicon Detectors

Brookfield Renewable Partners

NextEra Energy

Vestas Wind Systems A/S

Floating wind farms might be the next frontier in green energy. Here's what investors should know about the the top energy companies profiting at sea right now.

Top 5 Floating Wind Farm Stocks: Which Companies Are Going Deep In Clean Tech?

General Electric (GE) Healthcare unit's $80 million investment in API site in Lindesnes is aimed at increasing manufacturing capacity by 30% to meet future demand for iodinated contrast media.

General Electric (GE) Healthcare Arm Invests in Lindesnes Site

SPANGEREID, Norway--( BUSINESS WIRE )--GE Healthcare's Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway. The investment – which is creating around 100 new jobs – is part of GE Healthcare's broader commitment to address significant future global demand for iodinated contrast media, used in Xray and Computed Tomography (CT) procedures around the world to enhance visualization of organs, blood vessels and tissues across disease pathways.

GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

An intelligence officer for the Chinese government was sentenced to 20 years in prison on Wednesday for committing economic espionage and attempting to steal trade secrets from GE Aviation.

Chinese intelligence officer sentenced to 20 years for espionage targeting GE Aviation

After 8 months of rental on 3 wastewater treatment plants of the Severn Trent Water group, the performance of the Orege solutions has been fully validated. This resulted in significant improvements of the sludge characteristics and in sludge thickening, enabling a significant increase in the treatment capacity of anaerobic digesters and biogas production.

Orège sells three solutions to Severn Trent Water to improve the performance of anaerobic digestion and biogas production

Apple

Intel

Microsoft

Calpers, the California Public Employees' Retirement System, disclosed the third-quarter moves in a filing with the SEC.

Largest U.S. Pension Buys Up Apple, Intel, and 2 More Big Stocks

40% technical buy signals and rising. 20 new highs and up 30.26% in the last month.

General Electric - Steady Price Momentum

Cyclical stocks like General Electric are on fire so far in the fourth quarter. That's great for shareholders, but they get caught up in the euphoria.

News for General Electric Stock (GE)